U.S. Senators Charles Grassley, Richard Blumenthal and Herb Kohl have introduced the Medical Device Patient Safety Act, designed to give the Food and Drug Administration (FDA) tools to better monitor post-market performance of new medical …
Read the full story »
The Wall Street Journal reports that U.S. Sen. Charles Grassley expressed concern over the fact that a consultant list provided to him by Medtronic Inc. doesn’t include a doctor accused of falsifying data in a favorable study of the company’s Infuse bone-graft product.
As reported in The Wall Street Journal, the family of a California woman who received an off-label Infuse bone graft in a neck surgery and allegedly died from Infuse-related complications has filed a lawsuit against Infuse manufacturer Medtronic Inc.
Lieff Cabraser attorney Kent Klaudt discusses Infuse bone graft side effects and related lawsuits
